Literature DB >> 32968242

TMB - a histology-agnostic predictor of the efficacy of ICIs?

David Killock1.   

Abstract

Entities:  

Year:  2020        PMID： 32968242     DOI： 10.1038/s41571-020-00438-0

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Tumour mutational burden in treatment-resistant tumours - Authors' reply.

Authors:  Aurelien Marabelle; Fan Jin; Kevin Norwood; Deepti Aurora-Garg
Journal:  Lancet Oncol       Date:  2020-12       Impact factor: 41.316
  1 in total
  4 in total

1.  Neoantigen landscape in metastatic nasopharyngeal carcinoma.

Authors:  Mei Lin; Xiao-Long Zhang; Rui You; Qi Yang; Xiong Zou; Kai Yu; You-Ping Liu; Ru-Hai Zou; Yi-Jun Hua; Pei-Yu Huang; Jin Wang; Qi Zhao; Xiao-Bing Jiang; Jun Tang; Yang-Kui Gu; Tao Yu; Gui-Ping He; Yu-Long Xie; Zhi-Qiang Wang; Ting Liu; Si-Yuan Chen; Zhi-Xiang Zuo; Ming-Yuan Chen
Journal:  Theranostics       Date:  2021-04-19       Impact factor: 11.556

2.  Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers.

Authors:  Mengjing Cui; Qianqian Xia; Xing Zhang; Wenjing Yan; Dan Meng; Shuqian Xie; Siyuan Shen; Hua Jin; Shizhi Wang
Journal:  Front Genet       Date:  2022-01-11       Impact factor: 4.599

3.  Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer.

Authors:  Hanqian Zeng; Shiwen Xu; Erjie Xia; Suzita Hirachan; Adheesh Bhandari; Yanyan Shen
Journal:  Aging (Albany NY)       Date:  2021-07-19       Impact factor: 5.682

4.  How to Choose a Survival Period? The Impact of Antibiotic Use on OS or PFS in NSCLC Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Authors:  Hua Chen; Ke-Dong Han; Zhi-Jiang He; Yi-Sheng Huang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.